The Journal of Immunology, Vol 149, Issue 8 2702-2708, Copyright © 1992 by American Association of Immunologists

ARTICLES

Autocrine growth limitation of human papillomavirus type 16-harboring keratinocytes by constitutively released tumor necrosis factor-alpha

J Malejczyk, M Malejczyk, A Kock, A Urbanski, S Majewski, N Hunzelmann, S Jablonska, G Orth and TA Luger
Department of Histology and Embryology, Warsaw Medical School, Poland.

TNF-alpha is known to exert antitumor and antiviral effects and to participate in the regulation of the immune response. In our study we demonstrate that human rTNF-alpha specifically blocks growth of SK-v keratinocyte cell line harboring and expressing human papillomavirus type 16 (HPV16) sequences. This inhibitory effect was shown by [3H]TdR incorporation and cell counting. Binding experiments with 125I-TNF- alpha showed that SK-v cells express about 10,000 single class TNF- alpha R per cell with affinity constant of about 0.7 nM. Binding of 125I-TNF-alpha could be inhibited by htr-9 mAb recognizing a 55/60-kDa type I TNF-alpha R but not by utr-1 mAb recognizing 75/80-kDa type II TNF-alpha R or irrelevant mAb specific for HPV16E7 protein. Addition of anti-TNF-alpha antibodies to SK-v cell culture resulted in significant (p < 0.05), dose-dependent stimulation of their proliferation. SK-v cells constitutively expressed TNF-alpha mRNA, and SK-v CM contained TNF-alpha, as demonstrated by Northern blot analysis, a specific ELISA, Western blot analysis, and a bioassay with TNF-alpha-sensitive L-M cells. HPLC gel filtration of SK-v cell CM showed that the factor cytotoxic for L-M cells coeluted with immunoreactive TNF-alpha. These results demonstrate that HPV16-harboring SK-v cells constitutively express and release immunoreactive and biologically active TNF-alpha that in turn may exert an autocrine growth inhibitory effect. This phenomenon could represent one of the self-limiting mechanisms controling growth of HPV-induced neoplasia.

This article has been cited by other articles:

				R. T. Simoes, M. A. G. Goncalves, E. A. Donadi, A. L. Simoes, J. S. R. Bettini, G. Duarte, S. M. Quintana, M. W. P. Carvalho, and E. G. Soares Association of Tumor Necrosis Factor a-2 and a-8 Microsatellite Alleles with Human Papillomavirus and Squamous Intraepithelial Lesions among Women in Brazil J. Clin. Microbiol., August 1, 2005; 43(8): 3932 - 3937. [Abstract] [Full Text] [PDF]

				R. D'Anna, H. Le Buanec, G. Alessandri, A. Caruso, A. Burny, R. Gallo, J.-F. Zagury, D. Zagury, and P. D'Alessio Selective Activation of Cervical Microvascular Endothelial Cells by Human Papillomavirus 16-E7 Oncoprotein J Natl Cancer Inst, December 19, 2001; 93(24): 1843 - 1851. [Abstract] [Full Text] [PDF]

				M. Scott, M. Nakagawa, and A.-B. Moscicki Cell-Mediated Immune Response to Human Papillomavirus Infection Clin. Vaccine Immunol., March 1, 2001; 8(2): 209 - 220. [Full Text] [PDF]

				C. L. Morin, R. H. Eckel, T. Marcel, and M. J. Pagliassotti High Fat Diets Elevate Adipose Tissue-Derived Tumor Necrosis Factor-{alpha} Activity Endocrinology, November 1, 1997; 138(11): 4665 - 4671. [Abstract] [Full Text] [PDF]

				H. zur Hausen and F. Rosl Pathogenesis of Cancer of the Cervix Cold Spring Harb Symp Quant Biol, January 1, 1994; 59(0): 623 - 628. [Abstract] [PDF]